Breaking News Instant updates and real-time market news.

TEVA

Teva

$21.87

0.26 (1.20%)

10:45
10/04/18
10/04
10:45
10/04/18
10:45

Teva call volume above normal and directionally bullish

Bullish option flow detected in Teva with 16,354 calls trading, 1.5x expected, and implied vol increasing almost 2 points to 50.09%. 10/5 weekly 22 calls and 10/5 weekly 21.5 calls are the most active options, with total volume in those strikes near 9,500 contracts. The Put/Call Ratio is 0.09. Earnings are expected on November 1st.

TEVA Teva
$21.87

0.26 (1.20%)

10/01/18
10/01/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. OPCO CUTS CHIPOTLE TO UNDERPERFORM: Oppenheimer analyst Brian Bittner downgraded Chipotle Mexican Grill (CMG) to Underperform from Perform with a $400 price target. Since its new CEO announcement in February, Chipotle is up 82% and has been upgraded 10 different times by the Street, Bittner noted. The company's "high-flying" valuation has "priced in" persistent mid-single same-store-sales and a path to at least $20 of earnings per share versus $8-$9 this year, the analyst added. His work suggests this earnings path is too optimistic, even when assuming "healthy sales." INTEL CUT TO UNDERWEIGHT BY BARCLAYS: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Underweight from Equal Weight and lowered his price target for the shares to $38 from $53. End-market tailwinds that propelled the run in shares, namely PC shortages and the slowing of server growth, are likely to reverse, Curtis believes. Further, the analyst expects Intel will see increased competition from AMD (AMD) and declining free cash flow returns. In addition, the names that have been floated in the CEO search "have yet to yield any disruptive potential candidates to take on all of these challenges," Curtis said. By squandering its manufacturing lead, the company now faces a "costly battle to retain share amidst a near-term slowing of its end markets," concluded the analyst. MKM CUTS INFINERA TO SELL: MKM Partners analyst Michael Genovese downgraded Infinera (INFN) to Sell from Neutral and lowered his price target to $5.50 from $10. The analyst said his checks suggest the company's loss of its biggest customer CenturyLink (CTL) to Ciena (CIEN) amid concerns with its ability to produce "new leading edge digital signal processors every 18-30 months". Genovese expects Infinera's upcoming guidance for Q4 and FY19 to be disappointing on revenues and margins, while his price target that assumes a valuation multiple of 0.8-times enterprise value to expected FY19 sales "reflects increasing concerns about the long-term competitiveness of the company." TEVA UPGRADED AT LEERINK, GOLDMAN: Leerink analyst Ami Fadia upgraded Teva (TEVA) to Market Perform from Underperform due to improving business fundamentals as well as the improving multiples for the overall generics sector. The analyst, who believes the company's fundamentals have improved meaningfully and put Teva in a position to pay down $3.5B in debt by YE18, raised his price target on the shares to $24 from $16. Meanwhile, Goldman Sachs analyst Jami Rubin added Teva to Goldman's Conviction List with a Buy rating, calling the recent selloff in the shares a "head scratcher." Recent concerns raised in the marketplace regarding second half of 2018 headwinds and Eli Lilly's (LLY) galcenuzemab approval were already expected and well understood, Rubin tells investors in a research note. DEUTSCHE CUTS LAM RESEARCH, APPLIED MATERIALS TO HOLD: Deutsche Bank analyst Sidney Ho downgraded Lam Research (LRCX) to Hold and lowered his price target for the shares to $170 from $230, and downgraded Applied Materials (AMAT) to Hold and lowered his price target for the shares to $43 from $58. Semicap Equipment stocks are not expensive but lack positive catalysts, Ho said. The analyst believes investor fears over that the industry has reached a cyclical peak will remain as long as the memory market stays weak. Further, he sees risk is for additional capex push-outs, especially in the first half of 2019.
10/01/18
10/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Outperform from Market Perform at BMO Capital with analyst Fadi Chamoun saying his meetings with institutional investors give him a more constructive outlook as the company proceeds with efforts to "add capacity across its network, implement automation," and (perform) other cost efficiency initiatives with medium-term benefits. 2. LogMeln (LOGM) upgraded to Outperform from Perform at Oppenheimer analyst Shaul Eyal saying in light of a soft 1H18 performance, the analyst views the company's recent retention concerns as gradually stabilizing per his industry checks. 3. Noble Corp. (NE) upgraded to Neutral from Underweight at Piper Jaffray with analyst Ian Macpherson saying he views the stock's risk/reward as balanced at current share levels. 4. Biogen (BIIB) assumed with an Overweight from Neutral at Cantor Fitzgerald. 5. Teva (TEVA) upgraded to Conviction Buy from Buy at Goldman Sachs and to Market Perform from Underperform at Leerink. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/01/18
10/01/18
UPGRADE
Target $24

Market Perform
Teva upgraded to Market Perform on improving fundamentals at Leerink
As previously reported, Leerink analyst Ami Fadia upgraded Teva to Market Perform from Underperform due to improving business fundamentals as well as the improving multiples for the overall generics sector. The analyst believes the company's fundamentals have improved meaningfully over the last few months as management has defended the Copaxone franchise maintaining brand share of about 85% despite two generic entrants, continued to grow Austedo, obtained timely approval of Ajovy and continued to rationalize costs faster than planned, which has put Teva in a position to pay down $3.5B in debt by YE18. Fadia also raised his price target on the shares to $24 from $16.
10/01/18
GSCO
10/01/18
UPGRADE
Target $30
GSCO
Conviction Buy
Teva upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Jami Rubin added Teva Pharmaceuticals (TEVA) to Goldman's Conviction List with a Buy rating. The analyst calls the recent selloff in the shares a "head scratcher" and sees a buying opportunity at current levels. Recent concerns raised in the marketplace regarding second half of 2018 headwinds and Eli Lilly's (LLY) galcenuzemab approval were already expected and well understood, Rubin tells investors in a research note. The analyst sees "meaningful upside" in shares of Teva and has a $30 price target for the name.

TODAY'S FREE FLY STORIES

14:10
08/19/19
08/19
14:10
08/19/19
14:10
General news
Treasury Action: Treasuries remain heavy »

Treasury Action:…

CHE

Chemed

$434.70

4.53 (1.05%)

14:09
08/19/19
08/19
14:09
08/19/19
14:09
Hot Stocks
Chemed VP Michael Witzeman sells almost $2M in company shares »

Chemed VP Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
08/19/19
08/19
14:05
08/19/19
14:05
General news
Fed's Rosengren said he believes monetary and fiscal policy are already accommodative »

Fed's Rosengren said…

AAPL

Apple

$211.93

5.49 (2.66%)

, MSFT

Microsoft

$138.27

2.14 (1.57%)

14:02
08/19/19
08/19
14:02
08/19/19
14:02
Periodicals
Microsoft hires former head of Apple's Siri efforts, The Information says »

Microsoft (MSFT) has…

AAPL

Apple

$211.93

5.49 (2.66%)

MSFT

Microsoft

$138.27

2.14 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 27

    Oct

RRR

Red Rock Resorts

$19.46

0.75 (4.01%)

, AES

AES Corp.

$15.46

0.25 (1.64%)

13:44
08/19/19
08/19
13:44
08/19/19
13:44
On The Fly
Fly Insider: Red Rock Resorts, Walgreen's among weeks notable insider trades »

Welcome to "Fly Insider,"…

RRR

Red Rock Resorts

$19.46

0.75 (4.01%)

AES

AES Corp.

$15.46

0.25 (1.64%)

GE

General Electric

$8.66

-0.13 (-1.48%)

MD

Mednax

$22.28

0.62 (2.86%)

CFR

Cullen/Frost

$85.74

0.95 (1.12%)

TWNK

Hostess Brands

$14.01

0.06 (0.43%)

WEN

Wendy's

$20.44

0.5 (2.51%)

PSA

Public Storage

$260.91

2.23 (0.86%)

AYX

Alteryx

$133.18

-0.57 (-0.43%)

WBA

Walgreens Boots Alliance

$51.40

1.3975 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 03

    Sep

  • 04

    Sep

  • 09

    Sep

  • 23

    Sep

  • 02

    Oct

  • 30

    Oct

  • 13

    Nov

GIG

GigCapital

$10.30

(0.00%)

13:43
08/19/19
08/19
13:43
08/19/19
13:43
Hot Stocks
GigCapital announces launching of de-SPACing efforts of Kaleyra combination »

GigCapital announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$12.42

-0.1 (-0.80%)

13:36
08/19/19
08/19
13:36
08/19/19
13:36
Hot Stocks
Breaking Hot Stocks news story on Avaya »

Avaya Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

RRC

Range Resources

$4.47

0.37 (9.02%)

13:35
08/19/19
08/19
13:35
08/19/19
13:35
Upgrade
Range Resources rating change  »

Range Resources rises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$12.39

-0.13 (-1.04%)

13:33
08/19/19
08/19
13:33
08/19/19
13:33
Periodicals
Avaya said to get bid from Mitel, Bloomberg says »

Mitel, which has gone…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

AVYA

Avaya

$12.38

-0.14 (-1.12%)

13:30
08/19/19
08/19
13:30
08/19/19
13:30
Hot Stocks
Breaking Hot Stocks news story on Avaya »

Avaya Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
08/19/19
08/19
13:17
08/19/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
08/19/19
08/19
13:16
08/19/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$211.42

4.98 (2.41%)

12:51
08/19/19
08/19
12:51
08/19/19
12:51
Periodicals
Apple Arcade to likely be priced at $4.99/month, 9to5Mac reports »

Apple Arcade,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSM

Fortuna Silver Mines

$3.67

-0.01 (-0.27%)

12:48
08/19/19
08/19
12:48
08/19/19
12:48
Hot Stocks
Fortuna Silver reports fatal accident at San Jose mine »

Fortuna Silver Mines said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVRA

Savara

$2.23

0.03 (1.36%)

12:40
08/19/19
08/19
12:40
08/19/19
12:40
Conference/Events
Savara management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

G

Genpact

$41.30

0.51 (1.25%)

, FB

Facebook

$186.67

3.25 (1.77%)

12:40
08/19/19
08/19
12:40
08/19/19
12:40
Periodicals
Facebook contractor raises wages for Indian content reviewers, Reuters reports »

Genpact (G), a Facebook…

G

Genpact

$41.30

0.51 (1.25%)

FB

Facebook

$186.67

3.25 (1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

KAR

KAR Auction

$25.67

0.18 (0.71%)

12:39
08/19/19
08/19
12:39
08/19/19
12:39
Conference/Events
KAR Auction management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 11

    Sep

  • 23

    Sep

  • 13

    Nov

ZS

Zscaler

$74.34

-6.5 (-8.04%)

12:37
08/19/19
08/19
12:37
08/19/19
12:37
Recommendations
Zscaler analyst commentary at OTR Global »

Zscaler slides after OTR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 10

    Oct

  • 15

    Oct

ENVA

Enova International

$24.92

0.31 (1.26%)

12:37
08/19/19
08/19
12:37
08/19/19
12:37
Conference/Events
Enova International management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 20

    Sep

  • 13

    Nov

AZN

AstraZeneca

$44.38

0.02 (0.05%)

12:33
08/19/19
08/19
12:33
08/19/19
12:33
Conference/Events
AstraZeneca management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 09

    Sep

  • 16

    Sep

  • 25

    Sep

  • 02

    Oct

PCG

PG&E

$10.35

-3.95 (-27.62%)

, AMGN

Amgen

$202.49

-1.46 (-0.72%)

12:22
08/19/19
08/19
12:22
08/19/19
12:22
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been rising…

PCG

PG&E

$10.35

-3.95 (-27.62%)

AMGN

Amgen

$202.49

-1.46 (-0.72%)

PANW

Palo Alto Networks

$196.50

-2.76 (-1.39%)

WB

Weibo

$41.70

4.65 (12.55%)

DRYS

DryShips

$5.19

1.355 (35.38%)

EL

Estee Lauder

$197.80

18.54 (10.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 19

    Aug

  • 04

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

LOW

Lowe's

$95.37

1.46 (1.55%)

, HD

Home Depot

$206.92

3.28 (1.61%)

12:19
08/19/19
08/19
12:19
08/19/19
12:19
On The Fly
Fly Intel: What to watch in Home Depot, Lowe's earnings reports »

Home improvement…

LOW

Lowe's

$95.37

1.46 (1.55%)

HD

Home Depot

$206.92

3.28 (1.61%)

JCP

J.C. Penney

$0.61

0.0122 (2.04%)

SHLD

Sears

$0.00

(0.00%)

AMZN

Amazon.com

$1,823.13

31.31 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 21

    Aug

  • 23

    Sep

  • 25

    Sep

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
08/19/19
08/19
12:17
08/19/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,202.00

25.06 (2.13%)

, GOOGL

Alphabet Class A

$1,204.36

25.67 (2.18%)

12:16
08/19/19
08/19
12:16
08/19/19
12:16
Hot Stocks
Trump says 'Google should be sued' over role in 2016 election »

President Donald Trump…

GOOG

Alphabet

$1,202.00

25.06 (2.13%)

GOOGL

Alphabet Class A

$1,204.36

25.67 (2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
08/19/19
08/19
12:16
08/19/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.